Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,873 total articles
Curanex Pharmaceuticals reports key first quarter 2026 progress including completion of GMP-compliant manufacturing and dose-range toxicology studies for its lead drug candidate Phyto-N targeting ulcerative colitis. The company plans an Investigational New Drug (IND) submission to the FDA in Q4 2026 and has expanded its pipeline strategy to include…
Formula Systems (1985) Ltd., a global IT holding company listed on Nasdaq and the Tel Aviv Stock Exchange, declared a special cash dividend totaling approximately $200 million or $13.045 per share for the fiscal year 2025. The dividend reflects the company's successful performance, including the completion of the Sapiens acquisition by Advent, and …
Sumitomo Forestry has completed the acquisition of Tri Pointe Homes for $47.00 per share, making Tri Pointe a wholly owned subsidiary. The combined operations will deliver approximately 15,000 homes annually across 18 states, positioning Sumitomo Forestry as the 5th largest homebuilder in the U.S. The acquisition enhances scale, operational efficie…
Senti Biosciences Holdings, Inc. reported first quarter 2026 financial results highlighting a positive FDA meeting that supports a single-arm pivotal trial for SENTI-202 targeting relapsed/refractory AML. The company secured a strategic financing agreement for up to $40 million and made operational efficiencies leading to reduced net loss and cash …
AIM ImmunoTech released a virtual investor segment featuring expert insights and positive interim results for Ampligen in treating late-stage pancreatic cancer. The data from the Named Patient Program and ongoing Phase 2 trial suggest improvements in progression-free and overall survival, underlining Ampligen's potential as an immunotherapeutic opt…
Senti Biosciences reported a successful FDA RMAT meeting focusing on the registrational clinical and CMC strategy for SENTI-202, an off-the-shelf CAR-NK cell therapy for relapsed/refractory AML. The company revealed that selecting Donor X phenotype for manufacturing improves efficacy, showing a 50% composite complete remission rate, and plans a sin…
GRI Bio, Inc. announced positive Phase 2a clinical trial results for GRI-0621 in idiopathic pulmonary fibrosis (IPF), demonstrating significant reductions in cough, dyspnea, and treatment-related diarrhea, along with improved lung function and no serious adverse events. The company is progressing its GRI-0803 program for autoimmune diseases and rep…
Biogen Inc. has completed the acquisition of Apellis Pharmaceuticals, adding two commercialized complement-targeting therapies, EMPAVELI® and SYFOVRE®, which generated $689 million in 2025 revenue. This acquisition accelerates Biogen's expansion into nephrology and is expected to be accretive to non-GAAP diluted EPS in 2027, supporting stronger gro…
Neuronetics announces a strategic collaboration with ANT Neuro to integrate ANT Neuro's visor2 neuronavigation system with the NeuroStar Advanced Therapy System, enhancing real-time spatial tracking and 3D visualization for more precise and personalized transcranial magnetic stimulation (TMS) treatments. This partnership aims to improve treatment c…
20/20 BioLabs, a Nasdaq-listed company specializing in AI-powered blood tests for early detection of cancer and chronic diseases, announced its CEO's participation in the Sidoti Micro-Cap Virtual Conference on May 20, 2026. The company will discuss recent quarterly results, partnership and licensing activities, and plans to scale its OneTest platfo…
Helport AI Limited has launched its next-generation AI-powered corporate website, demonstrating its flagship HyprX Expert Replication Engine. This new platform transforms traditional static websites into interactive AI labor environments, replicating expert human capabilities to enhance real-time customer interactions and enterprise workflows. Help…
BitFuFu Inc., a Nasdaq-listed Bitcoin mining company, announced April 2026 production metrics showing a decline in Bitcoin output primarily caused by a power outage at its Ethiopia facility and a strategic reduction in third-party hashrate procurement. Despite these setbacks, the company maintained steady self-owned hashrate, increased its Bitcoin …
Waldencast plc's Obagi Medical has partnered with Next Health to create "The Skin Recharge Station," a limited-time pop-up tour combining advanced skincare with wellness, introducing consumers to NAD+ science and Obagi's NU-GEN Cellular Renewal Serum, enhancing brand engagement and promoting healthy aging through innovative products and experiences…
Fiserv held its 2026 Investor Day presenting its One Fiserv action plan emphasizing disciplined strategy execution. The company projects adjusted and organic revenue growth of 1% to 3% for 2026 and forecasts medium-term compounded annual growth rates of 4% to 6%, with operating margins surpassing 37% by 2029. Fiserv expects adjusted earnings per sh…
LPL Financial has been honored with two Stevie Awards in the 2026 American Business Awards for its leadership in integrating artificial intelligence into its AccountView Next Gen digital wealth platforms. The awards recognize the firm's achievements in AI-powered personalized investment insights and comprehensive generative AI deployment on mobile,…
Prenetics Global Limited announces the appointment of Brian J. Rosin as U.S. Chief Financial Officer for IM8, its premium health and longevity brand co-founded with David Beckham. Rosin brings nearly 20 years of financial leadership in consumer e-commerce and wellness brands and will support IM8's rapid global expansion and financial strategy. IM8 …
Candel Therapeutics reported Q1 2026 financial results highlighting advancement towards a planned Biologics License Application (BLA) submission in Q4 2026 for aglatimagene besadenovec in localized prostate cancer. The company announced extended survival data in NSCLC patients and plans to initiate a pivotal phase 3 trial for NSCLC in mid-2026. Com…
Quantum Cyber N.V. (Nasdaq: QUCY), focused on AI-powered autonomous defense technology, announced the appointment of Peter M. O'Rourke Sr., former Acting Secretary of the U.S. Department of Veterans Affairs, to its Board of Directors. O'Rourke brings valuable government, military, and Nasdaq board experience, supporting Quantum Cyber's strategic gr…
PROCEPT BioRobotics highlights the updated American Urological Association (AUA) guidelines strengthening the recommendation for its Aquablation therapy as a surgical option for benign prostatic hyperplasia (BPH). The guidelines now support Aquablation for prostate volumes 30–80 mL and recognize its use in larger prostates (80–150 mL), supported by…
Cingulate Inc. announced its Q1 2026 financial results showcasing a significantly strengthened balance sheet with $25.9 million in cash and an improved working capital position. The company continues to advance commercial readiness for its lead ADHD asset, CTx-1301, leveraging its proprietary Precision Timed Release platform. The NDA for CTx-1301 i…
Apyx Medical Corporation announced the publication of a retrospective clinical study demonstrating that adding their Renuvion helium plasma radiofrequency technology to liposuction significantly improves patient satisfaction with abdominal appearance and excess skin, reduces the need for abdominoplasty and revisions, while maintaining comparable co…
Mobilicom Limited announced its participation in SOF Week 2026, engaging with defense customers and stakeholders to discuss its portfolio of cybersecure autonomous drone and robotics technologies designed for special operations. The company plans to highlight its SkyHopper Tactical platform with FCC Trusted Drone status, aiming to meet evolving ope…
Aureus Greenway Holdings Inc. (Nasdaq: AGH) will change its ticker symbol to PUSA, effective May 15, 2026, aligning with its anticipated merger this summer with Autonomous Power Corporation (Powerus), a leader in autonomous drone and defense technologies. Upon closing, the combined entity will operate as Powerus Corporation, focusing on defense, ho…
IN8bio presented translational data demonstrating that repeated dosing of its genetically modified gamma-delta T cell therapy, DeltEx DRI, preserves immune function, remodels the tumor microenvironment, and correlates with improved survival outcomes in glioblastoma. Advanced analytical methods integrating AI, immunogenomics, and spatial transcripto…
Off The Hook YS Inc., a U.S.-based AI-powered marine marketplace, has completed the acquisition of Apex Marine Companies, enhancing its operational efficiency, refurbishment capabilities, and global sales reach. The acquisition adds key South Florida facilities and skilled teams, enabling in-house servicing and refurbishment of vessels, reducing co…
